Filing Flows › Vycor Medical (VYCO) › Q1 2026 › vs Q4 2025
Vycor Medical (VYCO) Q1 2026 vs Q4 2025 (quarter over quarter)
Vycor Medical's revenue rose $42K (+10%) from $417K in Q4 2025 to $459K in Q1 2026. The biggest changes: Vycor Medical Inc +$37K (+9%); Nova Vision Inc +$5K (+37%). Gross margin 81.8% against 80.4% (+1.4 pts).
Vycor Medical, Q1 2026: revenue $459K (+5% year over year), operating margin 10.0%, net earnings $20K, operating cash flow $99K. The chart draws each line against Q4 2025, the increases inside each band.
Margins
| Q1 2026 | Q4 2025 | Change | |
|---|---|---|---|
| Gross margin | 81.8% | 80.4% | +1.4 pts |
| Operating margin | 10.0% | -8.8% | +18.8 pts |
| Net margin | 4.4% | -15.0% | +19.4 pts |
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Vycor Medical Inc | $440K | $404K | $37K | +9% |
| Nova Vision Inc | $18K | $13K | $5K | +37% |
| Revenue | $459K | $417K | $42K | +10% |
| Gross profit | $375K | $335K | $40K | +12% |
| Cost of revenue | $83K | $82K | $2K | +2% |
| Operating profit | $46K | −$37K | $82K | — |
| Operating expenses | $329K | $372K | −$43K | -11% |
| Pre-tax earnings | $20K | −$62K | $82K | — |
| Other expense, net | $26K | $26K | −$141 | -0.5% |
| SG&A | $315K | $357K | −$42K | -12% |
| Other operating costs | $14K | $15K | −$1K | -6% |
| Income tax benefit | $13 | −$307 | $320 | — |
| Net earnings | $20K | −$63K | $83K | — |
| Depreciation & amortization | $14K | $15K | −$1K | -6% |
| Working capital & other | $65K | $87K | −$22K | -25% |
| Operating cash flow | $99K | $39K | $60K | +153% |
Questions
How much did Vycor Medical's revenue grow quarter over quarter in Q1 2026?
Vycor Medical's revenue rose $42K (+10%) from $417K in Q4 2025 to $459K in Q1 2026.
What drove Vycor Medical's revenue change in Q1 2026?
Vycor Medical Inc +$37K (+9%); Nova Vision Inc +$5K (+37%).